Risedronate Sodium API | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Risedronate Sodium API
US Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Risedronate Sodium API

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 11 EU WC, 27 KDMF, 9 NDC API, 25 Listed Suppliers, $ API Reference Price

67 API Suppliers
16 USDMF
8 CEP/COS
6 JDMF
11 EU WC
27 KDMF
9 NDC API
25 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

230 FDF Dossiers, 38 FDA Orange Book, 143 Europe, 4 Canada, 23 Australia, 5 South Africa, 17 Listed Dossiers

230 FDF Dossiers
38 FDA Orange Book
143 Europe
4 Canada
23 Australia
5 South Africa
17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 30MG, TABLET;ORAL - 35MG, TABLET;ORAL - 5MG, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 35MG

TABLET;ORAL - 150MG
TABLET;ORAL - 30MG
TABLET;ORAL - 35MG
TABLET;ORAL - 5MG
TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - 35MG

DIGITAL CONTENT

10 News #PharmaBuzz

10 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 121 Regulatory FDF Prices, 1 Annual Reports

12 US Medicaid Prescriptions
121 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

5 APIs

5 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 10 Health Canada Patents

3 US Patents
10 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 JP, 8 Others

3 EDQM
3 JP
8 Others

$ API Ref.Price (USD/KG) : 992 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3APIL

filter Patent Number Reset all filters

3 All

01 17645459

02 17645460

03 18246989

API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 12026-01-16

02 22028-01-09

Product Main Page

01

APIL

RISEDRONATE SODIUM

ESCRS

Not Confirmed

APIL

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-01-09

RISEDRONATE SODIUM

US Patent Number : 7645460

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22560

Patent Use Code : U-662

Delist Requested :

Patent Use Description : TREATMENT OF OSTEOPORO...

Patent Expiration Date : 2028-01-09

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

APIL

RISEDRONATE SODIUM

ESCRS

Not Confirmed

APIL

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-01-09

RISEDRONATE SODIUM

US Patent Number : 7645459

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22560

Patent Use Code : U-662

Delist Requested :

Patent Use Description : TREATMENT OF OSTEOPORO...

Patent Expiration Date : 2028-01-09

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

APIL

RISEDRONATE SODIUM

ESCRS

Not Confirmed

APIL

Country

ESCRS

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-01-16

RISEDRONATE SODIUM

US Patent Number : 8246989

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22560

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-16

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!